October 03, 2024
Trending Now
1
Regulator Reviews Hair-Loss Drugs Over Suicide Risk
2
Experts Urged Caution on Mouth Taping Trend
3
Thyroid Cancer Radioactive Iodine Tied to Melanoma Risk
4
Roflumilast Cream Effective for Atopic Dermatitis in Phase III Trials
5
French Study Uncovers EN Mortality, Sequelae Patterns
6
Omalizumab Boosts Tolerance to Food Allergens: Study
Conference Coverage
2024 ASCO Annual Meeting
SSO 2021 International Conference on Surgical Cancer Care
AACR Annual Meeting 2023
Clinical Guidelines
View MoreJune 01, 2023
Check the Lids for Demodex Blepharitis
February 01, 2023
Pricing and Packaging Cataract Surgery
May 01, 2023
INNOVATION
January 01, 2024
Streamlining Layered Composite Veneer Procedures
Commentary & Perspectives
View MoreOctober 03, 2024
Experts Urged Caution on Mouth Taping Trend
FDA & Government News
View MoreOctober 04, 2024
Regulator Reviews Hair-Loss Drugs Over Suicide Risk
October 03, 2024
Melania Trump Backs Abortion Rights
October 03, 2024
First Emergency-Use Mpox Diagnostic Test Approved
September 25, 2024
FDA Approves IND for Liquid Botulinum Toxin Formulation
Business Management
View MoreSeptember 30, 2024
More Females Entering High-Paying Specialties
September 27, 2024
U.S. Nonprofit Hospitals Gained $37.4B in 2021 Tax Benefits
September 23, 2024